Trials / Completed
CompletedNCT03844373
Tolerance and Acceptability Evaluation of STOCKHOLM
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Aymes International Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tolerance and Acceptability of new oral nutritional supplement - STOCKHOLM.
Detailed description
To evaluate tolerance and acceptability of 'STOCKHOLM' in patients requiring supplementary oral nutritional support compared with currently available alternatives. To obtain data to support an ACBS submissions for 'STOCKHOLM' (to allow for prescription in the community at NHS expense).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | STOCKHOLM | STOCKHOLM is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. |
Timeline
- Start date
- 2018-11-02
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2019-02-18
- Last updated
- 2021-01-06
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03844373. Inclusion in this directory is not an endorsement.